We founded the Swiss Ventures Group because the wealth of experience we have accumulated over the years is meant to be shared. Check out our news and find extensive background information on investments, startups and the world of VC.
In a recent podcast with IMD, Michael Stucky, Partner at Serpentine Ventures, discusses the critical skill of portfolio triage in VC, navigating market shifts, managing expectations, resources, and delivering tough decisions to founders.
Piomic, part of Serpentine Ventures, saw its technology reconfirmed as highly effective in a recent study, showcasing significant wound reduction and ease of use. New potential applications include autolytic debridement and pressure ulcers.
Biped, a Serpentine Ventures portfolio company, introduces new features for its NOA device. The device now helps visually impaired users locate doors, crosswalks, stairs, and read text, enhancing navigation in unfamiliar environments.
OneTwo Analytics, a Serpentine Ventures portfolio company, partners with Lifecare to introduce AI/ML-based analytics to the veterinary field, enhancing glucose data accessibility and advancing diabetes management for animals and humans.